NIH-funded research R01 grant

Periodontitis and HIV therapy–related bone loss in people living with HIV

Official title: Intersection of Periodontitis with HIV-Antiretroviral Therapy-Induced Immune Reconstitution Bone Loss, on Alveolar Bone and Tooth Loss, in People Living with HIV

Funded at Emory University · NIH-11323448 · Data updated 2026-11-12

A study exploring how HIV treatment–related immune changes can drive bone loss around the teeth in people with HIV, and how periodontitis may worsen this effect.

More Periodontitis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionEmory University
NIH-funded
Lab location1 site (Atlanta, United States)
Project startAugust 1, 2024
Project endApril 30, 2029
Funding year2026
Award (this year)$354,573
NIH project number5R01DE033635-03
Project IDNIH-11323448 on NIH RePORTER

Who could benefit from this research

Could help

People living with HIV who are initiating or on antiretroviral therapy and at risk for periodontal disease or bone loss of the jaw.

Less likely to help

Patients without periodontal disease or those not starting ART may see limited direct benefit.

What this research studies

This project looks at how HIV infection and antiretroviral therapy influence bone loss around the jaw and teeth. Researchers will use patient data and animal models to understand immune-driven bone damage, focusing on the alveolar bone that supports teeth. The work aims to connect inflammatory changes from immune reconstitution with changes in oral bone health in people living with HIV. Findings could point to interventions that protect oral bone and prevent tooth loss for patients starting ART. The study will be conducted at Emory University with collaboration from experienced researchers in HIV and dental health.

Why it matters

Potential benefit: If successful, the work could lead to strategies to prevent alveolar bone loss and tooth loss in people with HIV starting ART.

How similar studies have gone: Previous work has shown HIV-related bone loss and periodontal disease are linked; this study extends those findings to alveolar bone in the jaw.

Where this research is happening

  • Emory University
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Weitzmann, Mervyn Neale — Emory University
  • Study coordinator: Weitzmann, Mervyn Neale

Related research

Other NIH-funded projects on the same topics.

  • How HIV and HIV meds affect jaw bone and teeth

    This project looks at how HIV, its treatment, and immune changes may cause jawbone and tooth loss in people living with HIV.

    NIH research Emory University · Atlanta, United States · NIH-11596027

  • Periodontitis and HIV treatment–related bone loss in the jaw and teeth

    This project studies how HIV and its treatment affect jawbone and tooth loss in people living with HIV, aiming to understand and reduce bone damage around teeth.

    NIH research Emory University · Atlanta, United States · NIH-11596026

  • How HIV and its treatment affect bone and tooth health

    This study is looking at how HIV and the medications used to treat it can affect bone health in the jaw, which is important for keeping your teeth healthy, and it's aimed at helping people living with HIV understand and improve their oral health.

    NIH research Emory University · Atlanta, United States · NIH-11144466

  • Oral-Gut–Bone Links in Periodontitis and Bone Loss

    This research explores how gum disease could affect bone health by studying the connection between the mouth, gut, and bones in adults.

    NIH research Indiana University Indianapolis · Indianapolis, United States · NIH-11441853

  • How bacteria affect bone loss in periodontal disease

    This study is looking at how certain bacteria that cause gum disease affect bone cells in your jaw, which can lead to tooth loss, and it aims to find new ways to help people who aren't getting better with current treatments.

    NIH research Augusta University · Augusta, United States · NIH-11119127

  • New treatment to stop bone loss in severe gum disease

    This study is testing a new treatment to help prevent bone loss in your jaw caused by severe gum disease, using a special antibody to target certain proteins, and it's designed for adults dealing with this common issue.

    NIH research Panorama Research, INC. · Sunnyvale, United States · NIH-10822066

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.